Lakmal W. Boteju

Person

Cedar, NJ, US

People

Patents Grantslast 30 patents

Information Patent Grant
Use of GAL3 antagonist for treatment of depression and/or anxiety a...
- Patent number 7,465,750
- Issue date Dec 16, 2008
- H. Lundbeck A/S
- Thomas P. Blackburn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Use of GAL3 receptor antagonists for the treatment of depression an...
- Publication number 20090318504
- Publication date Dec 24, 2009
- Thomas P. Blackburn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of GAL3 antagonist for treatment of depression and/or anxiety a...
- Publication number 20070259942
- Publication date Nov 8, 2007
- Thomas P. Blackburn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of GAL3 antagonist for treatment of depression
- Publication number 20040127502
- Publication date Jul 1, 2004
- Synaptic Pharmaceutical Corporation
- Thomas P. Blackburn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds for the treatment of pain
- Publication number 20030176314
- Publication date Sep 18, 2003
- Carlos C. Forray
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Molecules specific for NPFF receptors and uses thereof
- Publication number 20030144310
- Publication date Jul 31, 2003
- Lakmal W. Boteju
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Guanidines which are agonist/antagonist ligands for neuropeptide FF...
- Publication number 20030139431
- Publication date Jul 24, 2003
- Joel K. Kawakami
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of GAL3 receptor antagonists for the treatment of depression an...
- Publication number 20030078271
- Publication date Apr 24, 2003
- Thomas P. Blackburn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Lakmal W. Boteju

Person

Patents Grantslast 30 patents

Use of GAL3 antagonist for treatment of depression and/or anxiety a...

Patents Applicationslast 30 patents

Use of GAL3 receptor antagonists for the treatment of depression an...

Use of GAL3 antagonist for treatment of depression and/or anxiety a...

Use of GAL3 antagonist for treatment of depression

Compounds for the treatment of pain

Molecules specific for NPFF receptors and uses thereof

Guanidines which are agonist/antagonist ligands for neuropeptide FF...

Use of GAL3 receptor antagonists for the treatment of depression an...